Updates

Tweets by @cellcentric

All our updates and events through tweets

Another site active; CellCentric’s CCS1477 haematology clinical programme. Many thanks to Paresh Vyas and the team at Oxford. pic.twitter.com/eeiFw5nMDK

CellCentric one of the ambassador co’s for UK biotech sector today at Parliament. Turning world leading research into novel healthcare products. @BIA_UK pic.twitter.com/D7wooMQobQ

Delighted to have another centre open for our haem malignancy clinical programme. CCS1477 first-in-class p300/CBP inhibitor in Phase I/II. pic.twitter.com/u01IEFiD6i

How we operate our clinical operations function, flexibly and expediently... New blog: cellcentric.com/updates/blog-n… pic.twitter.com/ARU9xDd4YY

Great to have Laura joining the clinical ops team today. Clinical studies of CCS1477 continue to ramp up; prostate cancer, haems, targeted tumours. pic.twitter.com/dpMziZI3nQ

New paper by Yu et al., in Molecular Cell. Androgen Receptor co-activation complexes including p300: cell.com/molecular-cell… pic.twitter.com/xivLnWKr27

Our locations

Get in touch

Contact us